https://www.m-ventures.com/news/obseva-announces-results-of-the-implant-phase-2-trial-of-obe001-nolasiban-for-the-improvement-of-pregnancy-and-live-birth-rates-
ObsEva Announces Results of the IMPLANT Phase 2 Trial of OBE001 (nolasiban) for the Improvement of...
https://www.clinicaltrialsarena.com/news/obseva-nolasiban-phaseiii-discontinues/
ObsEva plans to halt clinical programme of IVF nolasiban drug
Dec 24, 2019 - ObsEva has decided to stop the current clinical development programme of nolasiban IVF after the drug failed in the Phase III IMPLANT 4 trial in Europe.
programme ofplanshaltclinicalivf